Khan, S. et al. 2024. Failure of the PD-1 blocking agent pembrolizumab to benefit a patient with renal squamous cell cancer. European Journal of Case Reports in Internal Medicine. 11, 7 (Jun. 2024). DOI:https://doi.org/10.12890/2024_004619.